The effect of covalently immobilized rhIL-1ra-ELP fusion protein on the inflammatory profile of LPS-stimulated human monocytes

被引:37
作者
Kim, Dong-Hwan
Smith, Jason T.
Chilkoti, Ashutosh
Reichert, William M.
机构
[1] Department of Biomedical Engineering, Duke University, Durham, NC 27708
关键词
IL-1ra; monocytes; cytokines; inflammation; wound healing; INTERLEUKIN-1 RECEPTOR ANTAGONIST; TUMOR-NECROSIS-FACTOR; SURFACE-PLASMON RESONANCE; MONONUCLEAR-CELLS INVITRO; GROWTH-FACTOR; MESSENGER-RNA; LIGAND-BINDING; BIOMATERIALS; INDUCTION; RESPONSES;
D O I
10.1016/j.biomaterials.2007.04.010
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
The objective of this research was to investigate whether immobilized anti-inflammatory cytokines will signal changes in the inflammatory profile of cultured monocytes. A fusion protein of recombinant human IL-I receptor antagonist and elastin-like peptide (IL-1ra-ELP) was expressed in Escherichia coh. THP-1 human monocytes were cultured on either carboxyl-terminated self-assembled monolayers (SAMs), or SAMs with either covalently immobilized or soluble IL-1ra-ELP. LPS-stimulated monocytes exposed to either soluble or immobilized IL-1ra-ELP were prevented from cell differentiation, showed attenuated expression of pro-inflammatory cytokines, and had increased production of anti-inflammatory and pro-wound healing cytokines. These results suggest that immobilized anti-inflammatory cytokines have the potential to be immunomodulatory biomaterials. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3369 / 3377
页数:9
相关论文
共 48 条
[1]   Interleukin-1 and neuronal injury [J].
Allan, SM ;
Tyrrell, PJ ;
Rothwell, NJ .
NATURE REVIEWS IMMUNOLOGY, 2005, 5 (08) :629-640
[2]   Engineering growing tissues [J].
Alsberg, E ;
Anderson, KW ;
Albeiruti, A ;
Rowley, JA ;
Mooney, DJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (19) :12025-12030
[3]   Biological responses to materials [J].
Anderson, JM .
ANNUAL REVIEW OF MATERIALS RESEARCH, 2001, 31 :81-110
[4]   BIOLOGICAL PROPERTIES OF RECOMBINANT HUMAN MONOCYTE-DERIVED INTERLEUKIN-1 RECEPTOR ANTAGONIST [J].
AREND, WP ;
WELGUS, HG ;
THOMPSON, RC ;
EISENBERG, SP .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (05) :1694-1697
[5]   Targeting IL-1 in inflammatory disease: New opportunities for therapeutic intervention [J].
Braddock, M ;
Quinn, A .
NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (04) :1-10
[6]   Interleukin-1 receptor antagonist [J].
Bresnihan, B ;
Cunnane, G .
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 1998, 24 (03) :615-+
[7]  
Bresnihan B, 1998, ARTHRITIS RHEUM, V41, P2196, DOI 10.1002/1529-0131(199812)41:12<2196::AID-ART15>3.3.CO
[8]  
2-U
[9]   In vivo leukocyte cytokine mRNA responses to biomaterials are dependent on surface chemistry [J].
Brodbeck, WG ;
Voskerician, G ;
Ziats, NP ;
Nakayama, Y ;
Matsuda, T ;
Anderson, JM .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2003, 64A (02) :320-329
[10]   CYTOKINES IN SYMPTOMATIC ASTHMA AIRWAYS [J].
BROIDE, DH ;
LOTZ, M ;
CUOMO, AJ ;
COBURN, DA ;
FEDERMAN, EC ;
WASSERMAN, SI .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1992, 89 (05) :958-967